Experimental evidence from CHOP knockout murine models and bone marrow transplantation studies with CHOP-deficient cells demonstrates significant retardation of tumor progression, confirming the central role of CHOP in MDSC-mediated immunosuppression. The gene discussed is DDIT3; the disease is neoplasm.